Alopecia clinical trials at University of California Health

11 in progress, 5 open to eligible people

Showing trials for

  • Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

    open to eligible people ages 6-17

    The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods,…

    at UCSD

  • Dupilumab in the Treatment of Pediatric Alopecia Areata

    open to eligible people ages 6-17

    This is a prospective, randomized, double-blind, placebo-controlled clinical trial. The study will take place at four sites. This trial will enroll a total of 76 children and adolescents with moderate to severe AA (affecting at least 30% of the…

    at UC Irvine

  • Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

    open to eligible people ages 21 years and up

    The purpose of this post-market, prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer.

    at UCSF

  • Regeneron AA Multicenter (Dupilumab)

    open to eligible people ages 18 years and up

    This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affecting more than 50% of the scalp) at the time of…

    at UC Irvine

  • Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

    open to all eligible people

    TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research…

    at UC Irvine UCSD

  • Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

    Sorry, in progress, not accepting new patients

    This is a parallel, Phase 2 multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study to investigate the efficacy and safety of subcutaneous (SC) injections of amlitelimab treatment as monotherapy in participants aged 18…

    at UC Irvine

  • Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

    Sorry, in progress, not accepting new patients

    Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the body. The purpose of this study is to assess how…

    at UC Davis UC Irvine

  • CTP-543 in Adults With Alopecia Areata

    Sorry, in progress, not accepting new patients

    The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.

    at UC Irvine

  • Fractional Photothermolysis for Hair Follicle Induction

    Sorry, in progress, not accepting new patients

    This study is being done to evaluate the effects of fractional photothermolysis (known as laser resurfacing) using fractional laser for the induction of hair follicles via skin rejuvenation in subjects with scalp alopecia (specifically, alopecia on…

    at UC Irvine

  • Long-Term PF-06651600 for the Treatment of Alopecia Areata

    Sorry, in progress, not accepting new patients

    This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B7931005…

    at UC Irvine UCSF

  • Alopecia Areata Registry

    Sorry, in progress, not accepting new patients

    Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.

    at UCSF

Our lead scientists for Alopecia research studies include .

Last updated: